Biogen Inc. Common Stock Earnings Dividend

Biogen Inc. Common Stock’s revenue jumped 1.93% since last year same period to $2477.8Mn in the Q1 2026. On a quarterly growth basis, Biogen Inc. Common Stock has generated 8.71% jump in its revenue since last 3-months.

Biogen Inc. Common Stock’s net profit jumped 32.85% since last year same period to $319.5Mn in the Q1 2026. On a quarterly growth basis, Biogen Inc. Common Stock has generated 759.97% jump in its net profits since last 3-months.

Biogen Inc. Common Stock’s net profit margin jumped 30.34% since last year same period to 12.89% in the Q1 2026. On a quarterly growth basis, Biogen Inc. Common Stock has generated 707.1% jump in its net profit margins since last 3-months.

Biogen Inc. Common Stock’s price-to-earnings ratio after this Q1 2026 earnings stands at 21.16.

Biogen Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at 1.94 - a -32.87% fall from last quarter’s estimates.

Biogen Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at 1.94.

Biogen Inc. Common Stock’s earning per share (EPS) jumped 18.21% since last year same period to 3.57 in the Q1 2026. This indicates that the Biogen Inc. Common Stock has generated 18.21% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Biogen Inc. Common Stock’s return on assets (ROA) stands at 0.06.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Biogen Inc. Common Stock’s return on equity (ROE) stands at 0.08.